when to increase tirzepatide dose for weight loss Switching Between Semaglutide and Tirzepatide: Efficacy, Dosing Protocols, and What Expect Acute Pancreatitis Likely Due collection:weightloss Quantity::10 MG

when to increase tirzepatide dose for weight loss Switching Between Semaglutide and Tirzepatide: Efficacy, Dosing Protocols, and What Expect Acute Pancreatitis Likely Due collection:weightloss Quantity::10 MG

Acute Pancreatitis Likely Due to Semaglutide - PMC

What stands out (investigator-initiated Phase 1): 🧑⚕️ 12 refractory SLE patients treated (including 10 biopsy-proven LN) at 3×10⁶ CAR-T/kg after lymphodepletion ✅ 9/10 LN achieved complete renal response (CRR) with stable eGFR and resolution of proteinuria in most 🧫 Repeat kidney biopsies in 9 patients (~1 year post-infusion) showed: marked histologic improvement (including reduction of active inflammatory lesions) clearance of immune-complex deposits on immunofluorescence (IgG/IgM/IgA/C3/C1q) 🧬 Broad autoantibody declines with early complement normalization (C3/C4) 🛡️ Safety profile reported as favorable: no ≥Grade 3 CRS or ICANS 🔁 Important nuance for LN endpoints: one case showed serologic clearance but persistent proteinuria attributed to irreversible chronic damage a reminder that proteinuria ≠ active nephritis in every patient Why this matters for LN trials and translational work: If a therapy can drive immune-complex clearance and histologic improvement, it moves the conversation closer to disease modification—and supports building future studies around standardized renal clinical + serologic + histologic endpoints

collection:weightloss

Quantity::10 MG

SEMAGLUTIDE For anyone who isn’t familiar with Semaglutide, this is one of a new class of proven weight loss medications that work as GLP-1 receptor agonists (also known as Wegovy and Ozempic)